Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Pasmant

Showing results (11-20 of 124) with videos related to

Pageof 13
Sort By:
NPJ Precision Oncology|February 10, 2024
NF1 mutations as biomarker of response to immune checkpoint blockades for lung adenocarcinoma patientsJean-Stéphane Giraud, Anne Jouinot, Eric Pasmant, et al.
Thrombosis Research|May 4, 2010
VKORC1 and CYP2C9 genetic polymorphisms in hepatic or portal vein thrombosisEric Pasmant, Charlotte de Beauvoir, Aurélie Plessier, et al.
Journal of Hepatology|October 10, 2020
COVID-19: Discovery, diagnostics and drug developmentTarik Asselah, David Durantel, Eric Pasmant, et al.
Journal of Neuro-Oncology|June 29, 2013
Relevance of MPNST cell lines as models for NF1 associated-tumorsEric Pasmant, Armelle Luscan, Jennifer Varin, et al.
Medecine Sciences : M/S|September 2, 2014
[PRC2 alterations in NF1-associated malignant peripheral nerve sheath tumors: schwann cells with no complex]Armelle Luscan, Dominique Vidaud, Nicolas Ortonne, et al.
European Journal of Haematology|June 23, 2011
A severe neonatal presentation of factor II deficiencyEric Pasmant, Bénédicte Dumont, Jean-Jacques Lacapere, et al.
American Journal of Medical Genetics. Part A|August 1, 2012
Two independent de novo mutations as a cause for neurofibromatosis type 1 and Noonan syndrome in a single familyEric Pasmant, Jeanne Amiel, Diana Rodriguez, et al.
Cancer Research|April 19, 2007
Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARFEric Pasmant, Ingrid Laurendeau, Delphine Héron, et al.
Haematologica|May 3, 2008
A natural variant with a point mutation resulting in a homozygous Arg to His substitution at position 388 in prothrombinClément d'Audigier, Eric Pasmant, Odile Bournier, et al.
Pathology International|January 21, 2017
Primary giant cell tumor of the common bile duct: No mutation H3F3A foundAurélie Beaufrère, Frédérique Larousserie, Safi Dokmak, et al.
Pageof 13

Showing results (11-20 of 124) with videos related to

Sort By:
Pageof 13
NPJ Precision Oncology|February 10, 2024
NF1 mutations as biomarker of response to immune checkpoint blockades for lung adenocarcinoma patientsJean-Stéphane Giraud, Anne Jouinot, Eric Pasmant, et al.
Thrombosis Research|May 4, 2010
VKORC1 and CYP2C9 genetic polymorphisms in hepatic or portal vein thrombosisEric Pasmant, Charlotte de Beauvoir, Aurélie Plessier, et al.
Journal of Hepatology|October 10, 2020
COVID-19: Discovery, diagnostics and drug developmentTarik Asselah, David Durantel, Eric Pasmant, et al.
Journal of Neuro-Oncology|June 29, 2013
Relevance of MPNST cell lines as models for NF1 associated-tumorsEric Pasmant, Armelle Luscan, Jennifer Varin, et al.
Medecine Sciences : M/S|September 2, 2014
[PRC2 alterations in NF1-associated malignant peripheral nerve sheath tumors: schwann cells with no complex]Armelle Luscan, Dominique Vidaud, Nicolas Ortonne, et al.
European Journal of Haematology|June 23, 2011
A severe neonatal presentation of factor II deficiencyEric Pasmant, Bénédicte Dumont, Jean-Jacques Lacapere, et al.
American Journal of Medical Genetics. Part A|August 1, 2012
Two independent de novo mutations as a cause for neurofibromatosis type 1 and Noonan syndrome in a single familyEric Pasmant, Jeanne Amiel, Diana Rodriguez, et al.
Cancer Research|April 19, 2007
Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARFEric Pasmant, Ingrid Laurendeau, Delphine Héron, et al.
Haematologica|May 3, 2008
A natural variant with a point mutation resulting in a homozygous Arg to His substitution at position 388 in prothrombinClément d'Audigier, Eric Pasmant, Odile Bournier, et al.
Pathology International|January 21, 2017
Primary giant cell tumor of the common bile duct: No mutation H3F3A foundAurélie Beaufrère, Frédérique Larousserie, Safi Dokmak, et al.
Pageof 13